Aller au contenu principal

Case details

Case Number: App_474739/2023

  • Patent number:
    EP3522923 - DOSING REGIMEN OF AVELUMAB FOR THE TREATMENT OF CANCER

  • Proceeding type: Application

  • Action/Application: Dérogation

  • Applicants:
    Clarivate Represented by Iva Matkovic

  • Court Division: appealInstance - seat - Luxembourg

  • Date of Formal receipt: 2023-06-02 19:17:51